Skip to main content
SpringerLink
Log in

Identification of RAB2A and PRDX1 as the potential biomarkers for oral squamous cell carcinoma using mass spectrometry-based comparative proteomic approach

  • Research Article
  • Published:
Tumor Biology

Abstract

Despite the recent advances in diagnostic and therapeutic strategies, oral squamous cell carcinoma (OSCC) remains a major health burden. Protein biomarker discovery for early detection will help to improve patient survival rate in OSCC. Mass spectrometry-based proteomics has emerged as an excellent approach for detection of protein biomarkers in various types of cancers. In the current study, we have used 4-Plex isobaric tags for relative and absolute quantitation (iTRAQ)-based shotgun quantitative proteomic approach to identify proteins that are differentially expressed in cancerous tissues compared to normal tissues. The high-resolution mass spectrometric analysis resulted in identifying 2,074 proteins, among which 288 proteins were differentially expressed. Further, it was noticed that 162 proteins were upregulated, while 125 proteins were downregulated in OSCC-derived cancer tissue samples as compared to the adjacent normal tissues. We identified some of the known molecules which were reported earlier in OSCC such as MMP-9 (8.4-fold), ZNF142 (5.6-fold), and S100A7 (3.5-fold). Apart from this, we have also identified some novel signature proteins which have not been reported earlier in OSCC including ras-related protein Rab-2A isoform, RAB2A (4.6-fold), and peroxiredoxin-1, PRDX1 (2.2-fold). The immunohistochemistry-based validation using tissue microarray slides in OSCC revealed overexpression of the RAB2A and PRDX1 gene in 80 and 68 % of the tested clinical cases, respectively. This study will not only serve as a resource of candidate biomarkers but will contribute towards the existing knowledge on the role of the candidate molecules towards disease progression and therapeutic potential.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Kreeft AM, Tan IB, Leemans CR, Balm AJ. The surgical dilemma in advanced oral and oropharyngeal cancer: how we do it. Clin Otolaryngol. 2011;36(3):260–6. doi:10.1111/j.1749-4486.2011.02299.x.

    Article  CAS  PubMed  Google Scholar 

  2. Ni YH, Ding L, Hu QG, Hua ZC. Potential biomarkers for oral squamous cell carcinoma: proteomics discovery and clinical validation. Proteomics: Clin Appl. 2015;9(1-2):86–97. doi:10.1002/prca.201400091.

    CAS  Google Scholar 

  3. Mangalath U, Aslam SA, Abdul Khadar AH, Francis PG, Mikacha MS, Kalathingal JH. Recent trends in prevention of oral cancer. J Int Soc Prev Community Dent. 2014;4 Suppl 3:S131–8. doi:10.4103/2231-0762.149018.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Perez-Sayans M, Somoza-Martin JM, Barros-Angueira F, Reboiras-Lopez MD, Gandara Rey JM, Garcia-Garcia A. Genetic and molecular alterations associated with oral squamous cell cancer (review). Oncol Rep. 2009;22(6):1277–82.

    Article  CAS  PubMed  Google Scholar 

  5. Mishra A, Verma V. Oral sex and HPV: population based indications. Indian J Otolaryngol Head Neck Surg. 2015;67 Suppl 1:1–7. doi:10.1007/s12070-012-0521-x 521.

    Article  PubMed  Google Scholar 

  6. Marur S, Forastiere AA. Head and neck cancer: changing epidemiology, diagnosis, and treatment. Mayo Clin Proc. 2008;83(4):489–501. doi:10.4065/83.4.489.

    Article  PubMed  Google Scholar 

  7. Turhani D, Krapfenbauer K, Thurnher D, Langen H, Fountoulakis M. Identification of differentially expressed, tumor-associated proteins in oral squamous cell carcinoma by proteomic analysis. Electrophoresis. 2006;27(7):1417–23. doi:10.1002/elps.200500510.

    Article  CAS  PubMed  Google Scholar 

  8. Marimuthu A, Chavan S, Sathe G, Sahasrabuddhe NA, Srikanth SM, Renuse S, et al. Identification of head and neck squamous cell carcinoma biomarker candidates through proteomic analysis of cancer cell secretome. Biochim Biophys Acta. 2013;1834(11):2308–16. doi:10.1016/j.bbapap.2013.04.029.

    Article  CAS  PubMed  Google Scholar 

  9. Pawar H, Kashyap MK, Sahasrabuddhe NA, Renuse S, Harsha HC, Kumar P, et al. Quantitative tissue proteomics of esophageal squamous cell carcinoma for novel biomarker discovery. Cancer Biol Ther. 2011;12(6):510–22. doi:10.4161/cbt.12.6.16833.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Syed N, Chavan S, Sahasrabuddhe NA, Renuse S, Sathe G, Nanjappa V, et al. Silencing of high-mobility group box 2 (HMGB2) modulates cisplatin and 5-fluorouracil sensitivity in head and neck squamous cell carcinoma. Proteomics. 2015;15(2-3):383–93. doi:10.1002/pmic.201400338.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Parida S, Parekh A, Dey G, Ghosh SC, Mandal M. Molecular inhibition of prostaglandin E2 with GW627368X: therapeutic potential and preclinical safety assessment in mouse sarcoma model. Cancer Biol Ther. 2015. doi:10.1080/15384047.2015.1040953.

    PubMed  PubMed Central  Google Scholar 

  12. Franchi A, Santucci M, Masini E, Sardi I, Paglierani M, Gallo O. Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck. Cancer. 2002;95(9):1902–10. doi:10.1002/cncr.10916.

    Article  CAS  PubMed  Google Scholar 

  13. Miyake N, Katoh O, Hirata S, Kimura S, Watanabe H, Yajin K. Expression of the Kruppel-type zinc finger gene, ZK7, in head and neck squamous cell carcinoma and normal mucosa. Cancer Lett. 2002;185(1):111–8.

    Article  CAS  PubMed  Google Scholar 

  14. Polachini GM, Sobral LM, Mercante AM, Paes-Leme AF, Xavier FC, Henrique T, et al. Proteomic approaches identify members of cofilin pathway involved in oral tumorigenesis. PLoS One. 2012;7(12):e50517. doi:10.1371/journal.pone.0050517.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Kaur J, Ralhan R. Differential expression of 70-kDa heat shock-protein in human oral tumorigenesis. Int J Cancer. 1995;63(6):774–9.

    Article  CAS  PubMed  Google Scholar 

  16. Kesting MR, Sudhoff H, Hasler RJ, Nieberler M, Pautke C, Wolff KD, et al. Psoriasin (S100A7) up-regulation in oral squamous cell carcinoma and its relation to clinicopathologic features. Oral Oncol. 2009;45(8):731–6. doi:10.1016/j.oraloncology.2008.11.012.

    Article  CAS  PubMed  Google Scholar 

  17. Feher LZ, Pocsay G, Krenacs L, Zvara A, Bagdi E, Pocsay R, et al. Amplification of thymosin beta 10 and AKAP13 genes in metastatic and aggressive papillary thyroid carcinomas. Pathol Oncol Res. 2012;18(2):449–58. doi:10.1007/s12253-011-9467-7.

    Article  CAS  PubMed  Google Scholar 

  18. Herold-Mende C, Andl T, Laemmler F, Reisser C, Eichhorn S. Expression and localization profile of tenascin in squamous cell carcinomas of the head and neck. HNO. 1999;47(8):723–9.

    Article  CAS  PubMed  Google Scholar 

  19. Bagutti C, Speight PM, Watt FM. Comparison of integrin, cadherin, and catenin expression in squamous cell carcinomas of the oral cavity. J Pathol. 1998;186(1):8–16. doi:10.1002/(SICI)1096-9896(199809)186.

    Article  CAS  PubMed  Google Scholar 

  20. Chiang WF, Hwang TZ, Hour TC, Wang LH, Chiu CC, Chen HR, et al. Calreticulin, an endoplasmic reticulum-resident protein, is highly expressed and essential for cell proliferation and migration in oral squamous cell carcinoma. Oral Oncol. 2013;49(6):534-–41. doi:10.1016/j.oraloncology.2013.01.003.

    Article  CAS  PubMed  Google Scholar 

  21. Gourin CG, Zhi W, Adam BL. Proteomic identification of serum biomarkers for head and neck cancer surveillance. Laryngoscope. 2009;119(7):1291–302. doi:10.1002/lary.20279.

    Article  CAS  PubMed  Google Scholar 

  22. Goel R, Muthusamy B, Pandey A, Prasad TS. Human protein reference database and human proteinpedia as discovery resources for molecular biotechnology. Mol Biotechnol. 2011;48(1):87–95. doi:10.1007/s12033-010-9336-8.

    Article  CAS  PubMed  Google Scholar 

  23. Barbaud A, Simon M, Parache RM, Serre G. Immunohistochemical characterization of the differentiation state of basal cell carcinomas with special interest for infiltrating relapsing tumors. Eur J Dermatol. 1998;8(5):320–4.

    CAS  PubMed  Google Scholar 

  24. Suda T, Tsunoda T, Uchida N, Watanabe T, Hasegawa S, Satoh S, et al. Identification of secernin 1 as a novel immunotherapy target for gastric cancer using the expression profiles of cDNA microarray. Cancer Sci. 2006;97(5):411–9. doi:10.1111/j.1349-7006.2006.00194.x.

    Article  CAS  PubMed  Google Scholar 

  25. Coulson-Thomas VJ, Coulson-Thomas YM, Gesteira TF, de Andrade Paula CA, Carneiro CR, Ortiz V, et al. Lumican expression, localization and antitumor activity in prostate cancer. Exp Cell Res. 2013;319(7):967–81. doi:10.1016/j.yexcr.2013.01.023.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Ping Lu Y, Ishiwata T, Asano G. Lumican expression in alpha cells of islets in pancreas and pancreatic cancer cells. J Pathol. 2002;196(3):324–30. doi:10.1002/path.1037.

    Article  PubMed  Google Scholar 

  27. Koninger J, Giese T, di Mola FF, Wente MN, Esposito I, Bachem MG, et al. Pancreatic tumor cells influence the composition of the extracellular matrix. Biochem Biophys Res Commun. 2004;322(3):943–9. doi:10.1016/j.bbrc.2004.08.008 S0006-291X(04)01735-8.

    Article  PubMed  Google Scholar 

  28. Leygue E, Snell L, Dotzlaw H, Hole K, Hiller-Hitchcock T, Roughley PJ, et al. Expression of lumican in human breast carcinoma. Cancer Res. 1998;58(7):1348–52.

    CAS  PubMed  Google Scholar 

  29. Naito Z, Ishiwata T, Kurban G, Teduka K, Kawamoto Y, Kawahara K, et al. Expression and accumulation of lumican protein in uterine cervical cancer cells at the periphery of cancer nests. Int J Oncol. 2002;20(5):943–8.

    CAS  PubMed  Google Scholar 

  30. Sun J, Feng X, Gao S, Xiao Z. microRNA-338-3p functions as a tumor suppressor in human non-small-cell lung carcinoma and targets Ras-related protein 14. Mol Med Rep. 2015;11(2):1400–6. doi:10.3892/mmr.2014.2880.

    CAS  PubMed  Google Scholar 

  31. Yoshida H, Miyachi M, Ouchi K, Kuwahara Y, Tsuchiya K, Iehara T, et al. Identification of COL3A1 and RAB2A as novel translocation partner genes of PLAG1 in lipoblastoma. Genes, Chromosomes Cancer. 2014;53(7):606–11. doi:10.1002/gcc.22170.

    Article  CAS  PubMed  Google Scholar 

  32. Nourashrafeddin S, Aarabi M, Modarressi MH, Rahmati M, Nouri M. The evaluation of WBP2NL-related genes expression in breast cancer. Pathol Oncol Res. 2014. doi:10.1007/s12253-014-9820-8.

    PubMed  Google Scholar 

  33. Wood ZA, Schroder E, Robin Harris J, Poole LB. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci. 2003;28(1):32–40.

    Article  CAS  PubMed  Google Scholar 

  34. Gong F, Hou G, Liu H, Zhang M. Peroxiredoxin 1 promotes tumorigenesis through regulating the activity of mTOR/p70S6K pathway in esophageal squamous cell carcinoma. Med Oncol. 2015;32(2):455. doi:10.1007/s12032-014-0455-0.

    Article  PubMed  Google Scholar 

  35. Yanagawa T, Ishikawa T, Ishii T, Tabuchi K, Iwasa S, Bannai S, et al. Peroxiredoxin I expression in human thyroid tumors. Cancer Lett. 1999;145(1-2):127–32.

    Article  CAS  PubMed  Google Scholar 

  36. Kim JH, Bogner PN, Ramnath N, Park Y, Yu J, Park YM. Elevated peroxiredoxin 1, but not NF-E2-related factor 2, is an independent prognostic factor for disease recurrence and reduced survival in stage I non-small cell lung cancer. Clin Cancer Res. 2007;13(13):3875–82. doi:10.1158/1078-0432.CCR-06-2893.

    Article  CAS  PubMed  Google Scholar 

  37. Neumann CA, Krause DS, Carman CV, Das S, Dubey DP, Abraham JL, et al. Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression. Nature. 2003;424(6948):561–5. doi:10.1038/nature01819.

    Article  CAS  PubMed  Google Scholar 

  38. Kim YJ, Lee WS, Ip C, Chae HZ, Park EM, Park YM. Prx1 suppresses radiation-induced c-Jun NH2-terminal kinase signaling in lung cancer cells through interaction with the glutathione S-transferase Pi/c-Jun NH2-terminal kinase complex. Cancer Res. 2006;66(14):7136–42. doi:10.1158/0008-5472.CAN-05-4446.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank the Indian Council of Medical Research (3/2/2/207/2013/NCD-III) and the Department of Science and Technology (SR/SO/BB-58/2008) Government of India for financial support.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Consent

Informed consent was obtained from all individual participants included in the study.

Conflicts of interest

None

Author information

Authors and Affiliations

  1. School of Medical Science and Technology, Indian Institute of Technology, Kharagpur, West Bengal, 721302, India

    Kaushik Kumar Dey, Ipsita Pal, Rashmi Bharti, Goutam Dey, B. N. Prashanth Kumar, Shashi Rajput, Aditya Parekh, Sheetal Parida, Priyanka Halder & Mahitosh Mandal

  2. Bankura Sammilani Medical College, Bankura, West Bengal, 722101, India

    Indranil Kulavi

Authors
  1. Kaushik Kumar Dey
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ipsita Pal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rashmi Bharti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Goutam Dey
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B. N. Prashanth Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shashi Rajput
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Aditya Parekh
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Sheetal Parida
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Priyanka Halder
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Indranil Kulavi
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Mahitosh Mandal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mahitosh Mandal.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(DOCX 13 kb)

ESM 2

(PDF 545 kb)

ESM 3

(PDF 2,550 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dey, K.K., Pal, I., Bharti, R. et al. Identification of RAB2A and PRDX1 as the potential biomarkers for oral squamous cell carcinoma using mass spectrometry-based comparative proteomic approach. Tumor Biol. 36, 9829–9837 (2015). https://doi.org/10.1007/s13277-015-3758-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-015-3758-7

Keywords

Search

Navigation